As phospho-Drp1 is previously known to be elevated in human and mouse AD, this raises the possibility of synergistic effect resulting from simultaneous elevation of both phospho-Drp1 and Fis1 in the setting of combined TBI and AD and could be a contributing factor to how TBI accelerates the onset and severity of AD. This evidence concerns the gene DNM1L and Alzheimer disease.